|Articles|October 9, 2000
Drugmaker Recalls Arthritis Medication
Advertisement
WASHINGTON - ESI Lederle announced last Thursday that it was recalling 4.2 million capsules of the arthritis drug etodolac because of contamination that could cause life-threatening complications in patients with heart conditions.
The company said that the recall will cover one lot of 300-milligram capsules, No. 9991052, which were distributed nationwide. For more information visit www.fda.gov.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
Ultrasonic Cleaning Is Not a Machine; It Is a Quality System: Preventing Hidden Bioburden in Surgical Instruments
2
How AI Reduces Surgical Delays and Prevents Complications: A Tampa Hospital Case Study
3
Dental Assistants Recognition Week Highlights Critical Role in Infection Prevention
4
Hospital-Onset Bacteremia in Burn Patients May Be a Poor Quality Metric, Study Finds
5